| Customization: | Available |
|---|---|
| Powder: | Yes |
| Customized: | Customized |
|
Still deciding? Get samples of US$ 480/kg
Request Sample
|
Suppliers with verified business licenses
Audited Supplier Audited by an independent third-party inspection agency
| Product Name | Paclitaxel |
| Appearance | White Powder |
| CAS NO. | 33069-62-4 |
| Molecular Formula | C47H51NO14 |
| Storage | Keep in a cool, dry, dark location |
Paclitaxe powder is a chemotherapy drug that is given as a treatment for some types of cancer. Paclitaxe powder is a mitotic inhibitor now used to treat patients with lung, ovarian, breast cancer, head and neck cancer, and advanced forms of Kaposi's sarcoma. Paclitaxe is also used for the prevention of restenosis.
Cancer Treatment: Paclitaxel is primarily used in the treatment of various types of solid tumors, notably ovarian cancer, breast cancer, and non-small cell lung cancer. Its potent antitumor activity targets and disrupts rapidly dividing cancer cells.
Combination Therapy: It is often administered in combination with other chemotherapeutic agents to enhance the treatment response and potentially overcome drug resistance in cancer patients.
Advanced or Metastatic Disease: For patients with advanced or metastatic stages of cancer, paclitaxel can help slow disease progression and improve overall survival outcomes.
Disrupts Cell Division: Paclitaxel works by interfering with the microtubular system within cells, specifically inhibiting the normal function of microtubules during mitosis (cell division). This leads to cell cycle arrest and ultimately, cell death in rapidly proliferating tumor cells.
Antimitotic Agent: As an antimitotic drug, it prevents cancer cells from undergoing proper mitosis, causing them to accumulate in the G2/M phase of the cell cycle. This accumulation disrupts the normal growth and proliferation of cancerous tissues.
Promotes Apoptosis: By inhibiting microtubule dynamics and cell division, paclitaxel triggers apoptosis (programmed cell death) in cancer cells. This selective killing of cancer cells helps to reduce tumor burden and may alleviate symptoms associated with the disease.
){kind=link}